PATENT CLAIM ANALYSIS

Application Number: 15861332
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "183000"]

Abstract:
Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed

Claim (Index 38):
The compound of  claim 37 , wherein each D is methyl.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 86.0
- Lexical Diversity: 1.40741
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13175218', '11920866', '14581462', '15049890', '14581453']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8371095670008919
- 35 USC 102 Novelty (BERT): 0.5542686555194483
- Combined Prediction Score: 0.8088254758527476
- Mean Citation Score: 421.739628
- Max Citation Score: 430.97195
- Similarity Product: 318.1664366338432

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test